These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission. Wang J, Zheng W, Liu F, Wang Y, He Y, Zheng L, Fan Q, Luo E, Cao Y, Cui L. Malar J; 2017 Nov 13; 16(1):458. PubMed ID: 29132428 [Abstract] [Full Text] [Related]
24. A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection. Yoneto T, Waki S, Takai T, Tagawa Yi, Iwakura Y, Mizuguchi J, Nariuchi H, Yoshimoto T. J Immunol; 2001 May 15; 166(10):6236-41. PubMed ID: 11342646 [Abstract] [Full Text] [Related]
27. Immunological studies in rodent malaria. I: Protective immunity induced in mice by mild strains of Plasmodium berghei yoelii against a virulent and fatal line of this plasmodium. Hargreaves J, Yoeli M, Nussenzweig RS. Ann Trop Med Parasitol; 1975 Sep 15; 69(3):289-99. PubMed ID: 1098589 [Abstract] [Full Text] [Related]
28. Particulate beta 1-3 glucan and casual prophylaxis of mouse malaria (Plasmodium berghei). Gillet J, Jacques PJ, Herman F. Adv Exp Med Biol; 1979 Sep 15; 121(A):307-13. PubMed ID: 121199 [No Abstract] [Full Text] [Related]
30. Parasite load stemming from immunization route determines the duration of liver-stage immunity. Patel H, Althubaiti N, Parmar R, Yadav N, Joshi U, Tyagi RK, Krzych U, Dalai SK. Parasite Immunol; 2019 Jul 15; 41(7):e12622. PubMed ID: 30854655 [Abstract] [Full Text] [Related]
31. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge. Wang T, Fujioka H, Drazba JA, Sam-Yellowe TY. Parasitol Res; 2006 Aug 15; 99(3):238-52. PubMed ID: 16541261 [Abstract] [Full Text] [Related]
32. The Plasmodium berghei-infection in isogenic F1 (C57Bl x DBA)-mice. I. The course of the infection and immunization experiments. Seitz HM. Tropenmed Parasitol; 1975 Dec 15; 26(4):417-25. PubMed ID: 766337 [Abstract] [Full Text] [Related]
34. Immunogenicity of soluble and particulate antigens from Leishmania donovani: effect of glucan as an adjuvant. Cook JA, Holbrook TW. Infect Immun; 1983 Jun 15; 40(3):1038-43. PubMed ID: 6852909 [Abstract] [Full Text] [Related]
35. Plasmodium berghei: use of free blood stage parasites to demonstrate protective humoral activity in the serum of recovered rats. Hamburger J, Kreier JP. Exp Parasitol; 1976 Oct 15; 40(2):158-69. PubMed ID: 786704 [No Abstract] [Full Text] [Related]
36. Plasmodium berghei merozoite surface protein-9: immunogenicity and protective efficacy using a homologous challenge model. Lopera-Mesa TM, Kushwaha A, Mohmmed A, Chauhan VS. Vaccine; 2008 Mar 04; 26(10):1335-43. PubMed ID: 18272263 [Abstract] [Full Text] [Related]
40. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy. de Moraes LV, Dechavanne S, Sousa PM, Barateiro A, Cunha SF, Nunes-Silva S, Lima FA, Murillo O, Marinho CRF, Gangnard S, Srivastava A, Braks JA, Janse CJ, Gamain B, Franke-Fayard B, Penha-Gonçalves C. Infect Immun; 2016 Jun 04; 84(6):1761-1774. PubMed ID: 27045035 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]